JPRN-jRCT2080222546
Unknown
Phase 2
Phase 2 study to evaluate efficacy and safety of DS-8500a in patients with Type 2 Diabetes Mellitus
DAIICHISANKYO Co.,Ltd.0 sites90 target enrollmentJune 30, 2014
ConditionsType 2 Diabetes Mellitus
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Type 2 Diabetes Mellitus
- Sponsor
- DAIICHISANKYO Co.,Ltd.
- Enrollment
- 90
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Main Inclusion Criteria;
- •Type 2 Diabetes Mellitus
Exclusion Criteria
- •Main Exclusion Criteria;
- •Type 1 Diabetes Mellitus
- •Patients under insulin treatment
- •Patients with hepatic disorder
- •Patients with renal disorder
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Effect of ayurvedic medicine drvyadi rasakriya in diabetesCTRI/2023/01/049263Aushadhi Bhavan
Completed
Phase 2
Phase II study assessing the efficacy and safety of lenvatinib for anaplastic thyroid cancer (HOPE)JPRN-UMIN000020773Translational Research Informatics Center, Foundation for Biomedical Research and Innovation39
Completed
Not Applicable
Phase II study evaluating efficacy and safety of peripheral blood stem cell harvest with bortezomib for multiple myelomaJPRN-UMIN000010258Fourth Department of Internal Medicine, Sapporo Medical University, School of Medicine30
Recruiting
Phase 2
uPBSCT with PTCY for ATadult T-cell leukemia/lymphomaJPRN-jRCTs031200375Fukuda Takahiro24
Recruiting
Not Applicable
Phase II study to evaluate efficacy and safety of retherapy with bendamustine and rituximab regimens in patients with relapsed/refractory indolent B-cell lymphomas and mantle cell lymphomasJPRN-UMIN000011152B-SRIM Study Group38